Chemotherapy-induced thrombocytopenia
Clinical trials for Chemotherapy-induced thrombocytopenia explained in plain language.
Never miss a new study
Get alerted when new Chemotherapy-induced thrombocytopenia trials appear
Sign up with your email to follow new studies for Chemotherapy-induced thrombocytopenia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to keep chemo on track for GI cancer patients
Disease control CompletedThis study tests whether avatrombopag, a pill that boosts platelet production, can help people with gastrointestinal cancer who develop low platelets from chemotherapy. About 60 participants will receive either avatrombopag or a placebo. The goal is to see if the drug can raise p…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase 2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for cancer patients: drug may prevent Chemo-Induced bleeding risk
Disease control CompletedThis study tested a drug called romiplostim in 165 adults with gastrointestinal, pancreatic, or colorectal cancer who were receiving chemotherapy. The goal was to see if romiplostim could prevent low platelet counts (thrombocytopenia) that often force doctors to delay or reduce c…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC